APOE-stratified Proteomic and Metabolomic Analysis Reveals Mitochondrial Dysfunction Inflammation and Lipid Dysregulation in Alzheimer's Disease.
Saved in:
| Title: | APOE-stratified Proteomic and Metabolomic Analysis Reveals Mitochondrial Dysfunction Inflammation and Lipid Dysregulation in Alzheimer's Disease. |
|---|---|
| Authors: | Li F; Institute For Informatics (I2), Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.; Department of Pediatrics, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Chen Y; Department of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.; NeuroGenomics and Informatics, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Western D; Department of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.; NeuroGenomics and Informatics, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Ali M; Department of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.; NeuroGenomics and Informatics, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Liu M; Department of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.; NeuroGenomics and Informatics, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Gong K; Department of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.; NeuroGenomics and Informatics, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Xu Y; Department of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.; NeuroGenomics and Informatics, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Lowery J; Department of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Holtzman DM; Department of Neurology, Knight Alzheimer's Disease Research Center, Hope Center for Neurological Disorders, ., St. Louis, Missouri, USA., Robins C; Human Genetics & Genomics, Research Technologies, GSK, Cambridge, MA, USA., Eicher JD; Human Genetics & Genomics, Research Technologies, GSK, Cambridge, MA, USA., Huang YN; Center For Neuroimaging, Indiana Alzheimer's Disease Research Center, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA., Liu S; Center For Neuroimaging, Indiana Alzheimer's Disease Research Center, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA., Park T; Center For Neuroimaging, Indiana Alzheimer's Disease Research Center, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA., Saykin AJ; Center For Neuroimaging, Indiana Alzheimer's Disease Research Center, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA., Nho K; Center For Neuroimaging, Indiana Alzheimer's Disease Research Center, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA., Moqri M; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Mohs RC; Global Alzheimer's Platform Foundation, Washington, DC, USA., Farinas A; The Phil and Penny Knight Initiative for Brain Resilience, Stanford University, Stanford, California, USA.; Wu Tsai Neurosciences Institute, Stanford University, Stanford, California, USA., Moran-Losada P; The Phil and Penny Knight Initiative for Brain Resilience, Stanford University, Stanford, California, USA.; Wu Tsai Neurosciences Institute, Stanford University, Stanford, California, USA., Oh HS; The Phil and Penny Knight Initiative for Brain Resilience, Stanford University, Stanford, California, USA.; Wu Tsai Neurosciences Institute, Stanford University, Stanford, California, USA.; Icahn School of Medicine at Mount Sinai, New York, New York, USA., Wyss-Coray T; The Phil and Penny Knight Initiative for Brain Resilience, Stanford University, Stanford, California, USA.; Wu Tsai Neurosciences Institute, Stanford University, Stanford, California, USA.; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA., Cruchaga C; Department of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.; NeuroGenomics and Informatics, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA. |
| Source: | Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2026 Apr; Vol. 13 (21), pp. e13872. Date of Electronic Publication: 2026 Feb 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844 (Electronic) Linking ISSN: 21983844 NLM ISO Abbreviation: Adv Sci (Weinh) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2198-3844 |
|---|---|
| DOI: | 10.1002/advs.202513872 |
